Relationship of Hospital Mortality with Metabolic Acidosis Severity in Critically Ill Patients
-
Mehrad Aghili
,
Mahdi Zangi
,
Mahmoud Reza Zinatzadeh
,
Elnaz Vahidi
,
Sepideh Aarabi
,
Ommolbanin Motamed
Abstract
Background: Metabolic acidosis (MA) is a common pathologic process with fatal consequences in critically ill (CI) patients. The more the severity of acidosis the more mortality rate is expected. To evaluate the relationship of hospital mortality with MA severity in CI patients admitted to emergency department (ED).
Methods: In this prospective cohort study, we enrolled CI patients (based on physician clinical assumption), most at level 1 or 2 emergency severity index triage system. Patients were followed and evaluated in 2 parallel groups, one with and the other without MA. The severity of acidosis, chief complaints, final diagnosis, demographic data, acute physiologic assessment and chronic health evaluation II (APACHE II) score, serum lactate and bicarbonate level, need for intubation and mechanical ventilation, admission ward, hospital length of stay and in hospital mortality were compared between the 2 groups.
Results: A total of 1811 CI patients including 60.2% males and 39.8% females with and without MA were evaluated. The most common age range was 65-55 years old (31.7%) with the meanSD of 61.348.23. The most common complaints and diagnoses were weakness (40.5%) and pneumosepsis (35.1%), respectively. Patients with severe acidosis had higher lactate level and APACHE II score (p<0.05). Mortality rate was 10.4%. Most of our cases had severe MA. Expired cases had higher lactate level and APACHE II score (p<0.05).
Conclusion: Lactate level, bicarbonate level and APACHE II score were all significant independent predictors of hospital mortality in CI patients.
[2] Smith I, Kumar P, Molloy S, Rhodes A, Newman P, Grounds R, et al. Base excess and lactate as prognostic indicators for patients admitted to intensive care. Intensive Care Med. 2001; 27(1):74-83.
[3] Santi M, Mcanulty G, Grounds M. Base excess and lactate as prognostic indicators for patients admitted to intensive care-15 years later. Intensive Care Med Exp. 2015; 3(1):1-2.
[4] Scheiner B, Lindner G, Reiberger T, Schneeweiss B, Trauner M, Zauner C, et al. Acid-base disorders in liver disease. J Hepatol. 2017; 67(5):1062-73.
[5] Funk GC, Doberer D, Kneidinger N, Lindner G, Holzinger U, Schneeweiss B. Acid–base disturbances in critically ill patients with cirrhosis. Liver Int. 2007; 27(7):901-9.
[6] Gunnerson KJ, Saul M, He S, Kellum JA. Lactate versus non-lactate metabolic acidosis: a retrospective outcome evaluation of critically ill patients. Crit Care. 2006; 10(1):1-9.
[7] Diler Y, Ozdemir S, Altunok I, Eroglu SE. Relationship between seizures and metabolic acidosis: a prospective observational study. Frontiers in Emergency Medicine. 2022;6(2):e20-e.
[8] Carson SS, Bach PB. The epidemiology and costs of chronic critical illness. Crit Care Clin. 2002; 18(3):461-76.
[9] Azoulay E, Adrie C, De Lassence A, Pochard F, Moreau D, Thiery G, et al. Determinants of postintensive care unit mortality: a prospective multicenter study. Crit Care Med. 2003;31(2):428-32.
[10] Vincent J-L, Quintairos e Silva A, Couto L, Taccone FS. The value of blood lactate kinetics in critically ill patients: a systematic review. Crit Care. 2016; 20(1):1-14.
[11] Gao F, Lin M-T, Yang X-Y, Cai M-X, Xie W, Huang Z-M. Metabolic acidosis in critically ill patients with cirrhosis: Epidemiology and short-term mortality risk factors. Turk J Gastroenterol. 2019; 30(10):883.
[12] Demirel B. Lactate levels and pneumonia severity index are good predictors of in‐hospital mortality in pneumonia. Clin Respir J. 2018; 12(3):991-5.
[13] Allyn J, Vandroux D, Jabot J, Brulliard C, Galliot R, Tabatchnik X, et al. Prognosis of patients presenting extreme acidosis (pH< 7) on admission to intensive care unit. J Crit Care. 2016; 31(1):243-8.
[14] Haas SA, Lange T, Saugel B, Petzoldt M, Fuhrmann V, Metschke M, et al. Severe hyperlactatemia, lactate clearance and mortality in unselected critically ill patients. Intensive Care Med. 2016; 42(2):202-10.
[15] Boniatti MM, Cardoso PR, Castilho RK, Vieira SR. Is hyperchloremia associated with mortality in critically ill patients? A prospective cohort study. J Crit Care. 2011; 26(2):175-9.
[16] Jung B, Rimmele T, Le Goff C, Chanques G, Corne P, Jonquet O, et al. Severe metabolic or mixed acidemia on intensive care unit admission: incidence, prognosis and administration of buffer therapy. A prospective, multiple-center study. Crit Care. 2011;15(5):1-9.
[17] Ammari AN, Schulze KF. Uses and abuses of sodium bicarbonate in the neonatal intensive care unit. Curr Opin Pediatr. 2002; 14(2):151-6.
[18] Aschner JL, Poland RL. Sodium bicarbonate: basically useless therapy. Pediatrics. 2008; 122(4):831-5.
[19] Wilson RF, Spencer AR, Tyburski JG, Dolman H, Zimmerman LH. Bicarbonate therapy in severely acidotic trauma patients increases mortality. J Trauma Acute Care Surg. 2013;74(1):45-50.
[20] Forsythe SM, Schmidt GA. Sodium bicarbonate for the treatment of lactic acidosis. Chest. 2000;117(1):260-7.
[21] Biradar S, Holyachi R, Teja VR. Severe metabolic acidosis in critically Ill patients and its association with the outcome in North Karnataka. 2021.
[22] Liu X, Shen Y, Li Z, Fei A, Wang H, Ge Q, et al. Prognostic significance of APACHE II score and plasma suPAR in Chinese patients with sepsis: a prospective observational study. BMC anesthesiology. 2015;16(1):1-9.
| Files | ||
| Issue | Vol 9 No Supp. 2 (2023): Supplement 2 |
|
| Section | Research Article(s) | |
| DOI | https://doi.org/10.18502/aacc.v9i6.14452 | |
| Keywords | ||
| Metabolic acidosis Critically ill patients Severity Mortality Emergency department | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
